Abstract:Deletion of microsomal prostaglandin E-2 synthase-1 (mPGES-1) inhibits inflammation and protects against atherosclerotic vascular diseases but displayed variable influence on pathologic cardiac remodeling. Overactivation of beta-adrenergic receptors (beta-ARs) causes heart dysfunction and cardiac remodeling, whereas the role of mPGES-1 in beta-AR-induced cardiac remodeling is unknown. Here we addressed this question using mPGES-1 knockout mice, subjecting them to isoproterenol, a synthetic nonselective agonist for beta-ARs, at 5 or 15 mg/kg per day to induce different degrees of cardiac remodeling in vivo. Cardiac structure and function were assessed by echocardiography 24 hours after the last of seven consecutive daily injections of isoproterenol, and cardiac fibrosis was examined by Masson trichrome stain in morphology and by real-time polymerase chain reaction for the expression of fibrosis-related genes. The results showed that deletion of mPGES-1 had no significant effect on isoproterenol-induced cardiac dysfunction or hypertrophy. However, the cardiac fibrosis was dramatically attenuated in the mPGES-1 knockout mice after either low-dose or high-dose isoproterenol exposure. Furthermore, in vitro study revealed that overexpression of mPGES-1 in cultured cardiac fibroblasts increased isoproterenol-induced fibrosis, whereas knocking down mPGES-1 in cardiac myocytes decreased the fibrogenesis of fibroblasts. In conclusion, mPGES-1 deletion protects against isoproterenol-induced cardiac fibrosis in mice, and targeting mPGES-1 may represent a novel strategy to attenuate pathologic cardiac fibrosis, induced by beta-AR agonists. SIGNIFICANCE STATEMENT Inhibitors of microsomal prostaglandin E-2 synthase-1 (mPGES-1) are being developed as alternative analgesics that are less likely to elicit cardiovascular hazards than cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs. We have demonstrated that deletion of mPGES-1 protects inflammatory vascular diseases and promotes post-myocardial infarction survival. The role of mPGES-1 in beta-adrenergic receptor-induced cardiomyopathy is unknown. Here we illustrated that deletion of mPGES-1 alleviated isoproterenol-induced cardiac fibrosis with-out deteriorating cardiac dysfunction. These results illustrated that targeting mPGES-1 may represent an efficacious approach to the treatment of inflammatory cardiovascular diseases.

Myeloid Cell Microsomal Prostaglandin E Synthase-1 Fosters Atherogenesis in Mice

Cell Selective Cardiovascular Biology Of Microsomal Prostaglandin E Synthase-1

Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis

Microsomal Prostaglandin E2 Synthase-1 Modulates the Response to Vascular Injury.

Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis

Abstract 14122: Myeloid Cell Mpges-1 Depletion Attenuates Mortality after Myocardial Infarction in Mice

Microsomal Prostaglandin E<sub>2</sub> Synthase-1 Deletion Attenuates Isoproterenol-Induced Myocardial Fibrosis in Mice

Abstract 147: Cell Selective Cardiovascular Biology of Mpges-1

Myeloid Cell Mpges-1 Deletion Attenuates Mortality Without Affecting Remodeling after Acute Myocardial Infarction in Mice

Myeloid cell mPGES-1 mediates inflammatory pain hypersensitivity in mice

Targeting Microsomal Prostaglandin E Synthase 1 to Develop Drugs Treating the Inflammatory Diseases.

Microsomal Prostaglandin Synthase-1-Derived Prostaglandin E-2 Protects Against Angiotensin Ii-Induced Hypertension Via Inhibition of Oxidative Stress

Myeloid Cell mPGES-1 Deletion Attenuates Calcium Phosphate-induced Abdominal Aortic Aneurysm in Male Mice

Microsomal prostaglandin E2 synthase-1 and its inhibitors: Molecular mechanisms and therapeutic significance

Mpges-1 Protects Against DOCA-Salt Hypertension Via Inhibition of Oxidative Stress or Stimulation of NO/cGMP

Disruption of the PGE synthesis / response pathway restrains atherogenesis in programmed cell death-1 (Pd-1) deficient hyperlipidemic mice

An Update of Microsomal Prostaglandin E Synthase-1 and PGE2Receptors in Cardiovascular Health and Diseases

Disruption of the PGE2 synthesis / response pathway restrains atherogenesis in programmed cell death-1 (Pd-1) deficient hyperlipidemic mice

Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice

Microsomal Prostaglandin E Synthase-1 Controls Colonic Prostaglandin E2 Production and Exerts a Protective Effect on Colitis Induced by Trinitrobenzene Sulfonic Acid in Mice

Lipopolysaccharide-Induced Expression of Microsomal Prostaglandin E Synthase-1 Mediates Late-Phase PGE2 Production in Bone Marrow Derived Macrophages